Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Scoles DR, Meera P, Schneider MD, Paul S, Dansithong W, Figueroa KP, Hung G, Rigo F, Bennett CF, Otis TS, Pulst SM.
Scoles DR, et al. Among authors: pulst sm.
Nature. 2017 Apr 20;544(7650):362-366. doi: 10.1038/nature22044. Epub 2017 Apr 12.
Nature. 2017.
PMID: 28405024
Free PMC article.